TJP aims to put its Canadian-made L!X nicotine pouches onto the US market

The US Food and Drug Administration (FDA) has received a premarket tobacco product application (PMTA) from Canadian manufacturer TJP Labs for its L!X nicotine pouches. The company said its application to sell the pouches in the US is now moving on to the next step of the PMTA process.

TJP’s CEO David Richmond-Peck said the pouches were launched by its subsidiary L!X Innovations for adults who could not or chose not to quit nicotine but wished to drop cigarettes in favour of non-combustible, oral-use products.

Read full article
I'm already a subscriber

Tiziana Cauli

Senior reporter/health & science editor
Tiziana is an Italian journalist from Sardinia. She has worked for both international and local media in Italy, South Africa, France, Spain, the UK, Lebanon and Belgium. She also worked as a communications manager for several international NGOs in the humanitarian sector. Tiziana holds a degree in Political Science and a PhD in African Studies from the University of Cagliari and she’s a graduate of the Carlo De Martino school of journalism in Milan.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation